TCM
TWST icon

Tygh Capital Management’s Twist Bioscience TWST Stock Holding History

Tygh Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2.16M Sell
27,912
-55
-0.2% -$5.64K 0.28% 77
2021
Q3 		$2.99M Buy
+27,967
New +$3.2M 0.4% 79

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tygh Capital Management's TWST Position: Q4 2021 in Review

Tygh Capital Management reduced its Twist Bioscience (TWST) stake by 0.2% in Q4 2021, selling an estimated $5.64K and leaving 27,912 shares worth $2.16M. The position accounts for 0.28% of the portfolio, ranked #77.

Tygh Capital Management first reported a position in TWST in Q3 2021 and has held it in 2 quarters since. The position peaked at $2.99M in Q3 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

  • Tygh Capital Management held 27,912 shares of Twist Bioscience worth $2.16M as of Q4 2021.
  • Tygh Capital Management sold 55 Twist Bioscience shares in Q4 2021, an estimated $5.64K.
  • Twist Bioscience made up 0.28% of Tygh Capital Management's portfolio in Q4 2021, its #77 holding.
  • Tygh Capital Management first reported a position in Twist Bioscience in Q3 2021 and has held it in 2 quarters since.
  • Tygh Capital Management's Twist Bioscience position peaked at $2.99M in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.